Serum-Based Proteomic Approach to Identify Clinical Biomarkers of Radiation Exposure
Cancers · 17.03.2025 · 17 (6) · 1010
DOI: 10.3390/cancers17061010 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cancers, online erschienen am 17.03.2025. Verfasst von Emeshaw Damtew Zebene und 7 weiteren Autor:innen. Beteiligte Einrichtung: Nuclear Medicine Unit, Department of Internal Medicine, College of Health Sciences, Addis Ababa University, Addis Ababa 9086, Ethiopia. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 60 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: International Atomic Energy Agency, Ministero della Salute.
Abstract (Originalsprache)
Background
Ionizing radiation (IR) exposure poses a significant health risk due to its widespread use in medical diagnostics and therapeutic applications, necessitating rapid and effective biomarkers for assessment.
Objective
The aim of this study is to identify the serum proteomic signature of IR exposure in patients undergoing radiotherapy (RT).
Methods
Blood samples were obtained from eighteen patients with head and neck cancer (HNC) and five patients with rectal cancer before and immediately after they underwent curative intensity-modulated radiotherapy (IMRT). The comprehensive serum proteome was analyzed in individual samples using nanoHPLC-MS/MS.
Results
Forty radiation-modulated proteins (RMPs), 24 upregulated and 16 downregulated, with a fold change ≥1.5 and p-value < 0.05 were identified. About 40% of the RMPs are involved in acute phase response, DNA repair, and inflammation; the key RMPs were ADCY1, HGF, MCEMP1, CHD4, RECQL5, MSH6, and ZNF224.
Conclusions
This study identifies a panel of serum proteins that may reflect the radiation response, providing a valuable molecular fingerprint of IR exposure and paving the way for the development of sensitive and specific biomarkers for early detection and clinical management of IR-related injuries.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Nuclear Medicine Unit, Department of Internal Medicine, College of Health Sciences, Addis Ababa University, Addis Ababa 9086, Ethiopia.
- Department of Microbial Cellular and Molecular Biology, College of Natural and Computational Sciences, Addis Ababa University, Addis Ababa 9086, Ethiopia.
- Experimental Pharmacology Unit, Laboratory of Naples and Mercogliano (AV), Istituto Nazionale Tumori-IRCCS-Fondazione G. Pascale, 80131 Naples, Italy.
- Experimental Animal Unit, Istituto Nazionale Tumori-IRCCS-Fondazione G. Pascale, 80131 Naples, Italy.
- Radiotherapy Center, College of Health Sciences, Addis Ababa University, Addis Ababa 9086, Ethiopia.
- Scientific Directorate, Istituto Nazionale Tumori-IRCCS-Fondazione G. Pascale, 80131 Naples, Italy.
ORCID-Profile: Emeshaw Damtew Zebene, Biagio Pucci, Hagos Tesfay Medhin, Elena Di Gennaro, Alfredo Budillon, Gurja Belay Woldemichael
Förderung
- International Atomic Energy Agency
- Ministero della Salute
Zitieren
APA
Zebene, E. D., Pucci, B., Lombardi, R., Medhin, H. T., Seife, E., Di Gennaro, E., Budillon, A., & Woldemichael, G. B. (2025). Serum-Based Proteomic Approach to Identify Clinical Biomarkers of Radiation Exposure. Cancers, 17(6), 1010. https://doi.org/10.3390/cancers17061010
Vancouver
Zebene ED, Pucci B, Lombardi R, Medhin HT, Seife E, Di Gennaro E, et al. Serum-Based Proteomic Approach to Identify Clinical Biomarkers of Radiation Exposure. Cancers. 2025;17(6):1010. doi:10.3390/cancers17061010
BibTeX
@article{Zebene2025,
author = {Zebene, Emeshaw Damtew and Pucci, Biagio and Lombardi, Rita and Medhin, Hagos Tesfay and Seife, Edom and Di Gennaro, Elena and Budillon, Alfredo and Woldemichael, Gurja Belay},
title = {Serum-Based Proteomic Approach to Identify Clinical Biomarkers of Radiation Exposure},
journal = {Cancers},
year = {2025},
volume = {17},
number = {6},
pages = {1010},
doi = {10.3390/cancers17061010}
}
EUVIMED